Navigate Up
Sign In

Franciscan Union ACO


Untitled Document
Untitled Document

The Franciscan Union Accountable Care Organization (ACO) was selected for the Medicare Shared Savings Program Accountable Care Organization in January 2013. Through the Medicare Shared Savings Program, Franciscan Union ACO will work with the Centers for Medicare and Medicaid Services to provide Medicare-fee-for-service beneficiaries with high quality service and care, while reducing the growth in Medicare expenditures through enhanced care coordination.

The partnership includes Franciscan Alliance and Union Hospital.

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.

Public Reporting​

Franciscan Union ACO
1515 W. Dragoon Trail
Mishawaka, IN 46544

ACO Primary Contact
Jennifer Westfall
(317) 782-7096
Jennifer.Westfall@franciscanalliance.org

Organizational Information

ACO Participants

ACO Governing Body

  • ​AlbertTomchaney, MD, Voting Member, ACO Participant, Franciscan St. Francis Health
  • Jay Brehm, Voting Member, ACO ParticipantFranciscan St. Francis Health
  • Robert J. Brody, Voting Member, ACO ParticipantFranciscan St. Francis Health
  • Hans Andreasen,  MDVoting Member, ACO ParticipantUnion Associated Physician Clinic
  • Virginia HayesVoting Member, ACO ParticipantProvidence Medical Group, LLC
  • George Bittar, MDVoting Member, ACO Participant, Providence Medical Group, LLC
  • James Bolinger, DOVoting Member, ACO ParticipantUnion Hospital
  • Pat Board, Voting Member, ACO ParticipantUnion Health System
  • Steve Hulman,  Voting Member, ACO Participant,Union Hospital
  • James W.Christee, Voting Member, Medicare beneficiary representative 

Key Clinical and Administrative Leadership

  • ACO Executive: Jenny Westfall
  • Medical Director: Dr. Doug Gillepsie
  • Compliance Official: Joy Heim

ACO Committees and Committee Leaderships


  • Professional Services Committee: John Bolinger, DO, Chair​
  • Finance and Operations Committee: Jay Brehm, Chair

Types of ACO Participants, or combinations of participants, that formed the ACO:

LLC with Hospital, Outpatient Centers and ACO providers

Aggregate Amount of Shared Savings/Losses

Performance Year 1/2013: $0
Performance Year 2/2014: $0​
Performance Year 3/2015: not yet determined

How Shared Savings Are Distributed

The ACO’s shared savings model includes both reinvestment in ACO infrastructure and payments to ACO participants to help coordinate care for Medicare Fee-for-Service beneficiaries.

33% of shared savings will be invested in ACO infrastructure, 33% will go to hospital facilities, and 33% will go to providers.


Quality Performance Results

Measure number​               ​Performance Measure​ Performance Year 1 
Summary Statistics      
                           ​
Performance Year 2 
Summary Statistics ​


ACO Performance Rate Mean Performance Rate for All ACOs​
    ACO Performance Rate
    Mean Performance Rate for All ACOs​
​(ACO-1) ​Getting Timely Care, Appointments, and Information  not in operations ​not in operations ​83.04 ​80.13
​(ACO-2) ​How Well Your Doctors Communicate  not in operations ​not in operations ​92.86 ​92.39
​(ACO-3) ​Patients’ Rating of Doctor  not in operations ​not in operations ​92.75 ​91.58
​(ACO-4) ​Access to Specialists
not in operations ​not in operations ​87.42 ​83.97
​(ACO-5) ​Health Promotion and Education  not in operations ​not in operations ​51.09 ​58.29
​(ACO-6) ​Shared Decision Making  not in operations ​not in operations ​72.97 ​74.6
​(ACO-7) ​Health Status/Functional Status
not in operations ​not in operations ​72.92 ​71.1
(ACO-8)​ ​Risk Standardized, All Condition Readmissions  ​14.59 ​14.90 ​15.36 ​15.15
​(ACO-9) ​ASC Admissions: COPD or Asthma in Older Adults  ​1.36 ​1.17
    ​1.15
​1.08
(ACO-10)​ ​ASC Admission: Heart Failure  ​1.17 ​1.20
    .95
​1.19
​(ACO-11) ​Percent of Primary Care Providers who Qualified for EHR Incentive Payment  ​72.00% ​ 66.21%​
    78.57%
​76.71%
​(ACO-12) ​Medication Reconciliation  not in operations ​not in operations ​99.70 ​82.61
​(ACO-13)​ ​Falls: Screening for Fall Risk  not in operations ​not in operations ​ 42.62 ​45.6
​(ACO-14)​ ​Influenza Immunization  not in operations ​not in operations ​62.44 ​57.51
​(ACO-15) ​Pneumococcal Vaccination  not in operations ​not in operations ​62.77 ​55.03
​(ACO-16) ​Adult Weight Screening and Follow-up

not in operations ​not in operations ​49.34 ​66.75
(ACO-17)​ ​Tobacco Use Assessment and Cessation Intervention  not in operations ​not in operations ​98.01 ​86.79
​(ACO-18) ​Depression Screening   not in operations ​not in operations ​41.00 ​39.27
​(ACO-19) ​Colorectal Cancer Screening  not in operations ​not in operations ​57.68 ​56.14
​(ACO-20) ​Mammography Screening  not in operations ​not in operations ​65.30 ​61.41
​Proportion of Adults who had blood pressure screened in past two years not in operations ​not in operations ​99.67 ​60.24
​Beneficiaries with diabetes who met all of the following criteria not in operations ​not in operations ​28.97 ​25.41
​(ACO-22) ​Hemoglobin A1c Control (HbA1c)
(<8 percent) 
not in operations ​not in operations ​72.52 N/A
​(ACO-23) ​Low Density Lipoprotein (LDL) (< 100 mg/dL)  not in operations ​not in operations ​55.30 N/A
​(ACO-24) ​Blood Pressure (BP) < 140/90  not in operations ​not in operations ​69.04 N/A
​(ACO-25) ​Tobacco Non-Use  not in operations ​not in operations ​96.19 N/A
​(ACO-26) ​Aspirin Use     not in operations ​not in operations ​89.60 N/A
​(ACO-27) ​Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)  not in operations ​not in operations ​16.56​ ​20.35
​(ACO-28) ​Percent of beneficiaries with hypertension whose BP < 140/90  not in operations ​not in operations ​67.70 ​68.02
​(ACO-29) ​Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl  not in operations ​not in operations ​47.80 ​57.29
​(ACO-30) ​Percent of beneficiaries who use Aspirin or other antithrombotic  not in operations ​not in operations ​ 88.51 ​80.79
​(ACO-31) ​Beta-Blocker Therapy for LVSD not in operations ​not in operations ​95.00 ​82.71
​Percent of beneficiaries with CAD who met all of the following criteria not in operations ​not in operations ​62.30 ​66.9
​(ACO-32) ​Drug Therapy for Lowering LDL-Cholesterol   not in operations ​not in operations 67.38 N/A
 (ACO-33)​ ​(ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) not in operations ​not in operations ​80.00 N/A
 


For more information on how to interpret scores on the above quality performance measures, see https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf​